Atlas Trials

Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone

Clinical trial NCT04090580 · COMPLETED

Trial details

NCT number
NCT04090580
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2019-10-27
Primary completion
2021-03-06
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.